Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nail keratin refers to a specialized group of hard, sulfur-rich intermediate filament proteins, primarily trichocyte keratins, that constitute the bulk of the nail plate. These proteins are divided into Type I (acidic, KRT31-KRT40) and Type II (basic-to-neutral, KRT81-KRT86) families, which heteropolymerize to form a dense, resilient matrix. The high cysteine content in these keratins allows for extensive disulfide bond formation, providing the nail with its characteristic hardness and resistance to chemical and mechanical stress.
In clinical pharmacology, nail keratin is a significant target because it acts as both a physical barrier to drug penetration and a reservoir for lipophilic and keratinophilic drugs like terbinafine and itraconazole. Genetic mutations in nail keratins, such as KRT6A or KRT16, lead to pachyonychia congenita, a rare condition characterized by severe nail hypertrophy, which is currently a target for experimental siRNA-based therapies. Additionally, the degradation of nail keratin by fungal keratinases is the primary mechanism of infection in onychomycosis, making the keratin matrix the focal point for antifungal treatment strategies.
Drugs interact with nail keratin through several mechanisms: antifungal agents like terbinafine and efinaconazole bind to the keratin matrix to create a long-lasting therapeutic reservoir; keratolytics like urea and salicylic acid disrupt hydrogen and disulfide bonds to soften or dissolve the keratin structure for debridement; and experimental RNA interference therapies target the mRNA of mutant keratins to prevent the formation of dysfunctional filaments in genetic disorders.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nail keratin (KRT).